×
About 6,403 results

ALLMedicine™ Retinal Detachment Center

Research & Reviews  2,354 results

Combination of Ranibizumab and Targeted Laser Photocoagulation
https://clinicaltrials.gov/ct2/show/NCT04444492

May 11th, 2022 - Retinal vein occlusion (RVO) is the second most common retinal vascular disease leading to visual impairment. Main cause for visual impairment in CRVO (Central Retinal Vein Occlusion) is macular edema (ME) while neovascularization of the retina an...

Pneumatic retinopexy as an approach to retinal detachment in a 30-weeks pregnant lady.
https://doi.org/10.1136/bcr-2022-249746
BMJ Case Reports; Markan A, Mittal H et. al.

May 11th, 2022 - Pneumatic retinopexy as an approach to retinal detachment in a 30-weeks pregnant lady.|2022|Markan A,Mittal H,Singla P,Singh R,|diagnostic imaging,surgery,surgery,

Outer retinal features in OCT predict visual recovery after primary macula-involving re...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9070941
PloS One; Hänsli C, Lavan S et. al.

May 6th, 2022 - To find predictive markers for the visual potential in optical coherence tomography (OCT) one month after surgical repair of macula-involving rhegmatogenous retinal detachment (miRD) with and without internal limiting membrane (ILM) peeling. This ...

see more →

Drugs  2 results see all →

Clinicaltrials.gov  70 results

Combination of Ranibizumab and Targeted Laser Photocoagulation
https://clinicaltrials.gov/ct2/show/NCT04444492

May 11th, 2022 - Retinal vein occlusion (RVO) is the second most common retinal vascular disease leading to visual impairment. Main cause for visual impairment in CRVO (Central Retinal Vein Occlusion) is macular edema (ME) while neovascularization of the retina an...

Combination Chemotherapy and Cyclosporine Followed by Focal Therapy for Bilateral Retinoblastoma
https://clinicaltrials.gov/ct2/show/NCT00110110

May 4th, 2022 - OBJECTIVES: Primary Compare the efficacy of neoadjuvant high-dose carboplatin and etoposide, vincristine, and cyclosporine (CSA) followed by ophthalmic focal therapy comprising cryotherapy and/or laser therapy to historical world data of chemother...

Prophylactic Intravitreal 5-Fluorouracil and Heparin to Prevent PVR in High-risk Patients With Retinal Detachment.
https://clinicaltrials.gov/ct2/show/NCT02834559

Apr 5th, 2022 - Proliferative vitreoretinopathy (PVR) is a common cause for postoperative failure after vitreoretinal surgery for primary RRD. There is no standard-therapy to prevent PVR. Several attempts using chemotherapeutic agents have been undertaken to prev...

Clinical Study Of Nearsightedness, TReatment With Orthokeratology Lenses 2
https://clinicaltrials.gov/ct2/show/NCT03774992

Mar 4th, 2022 - Myopia is a common disease of the eye with increasing prevalence in the Western World as well as in South East Asia where 60-90% of the children are affected. A Danish study found that early debut of myopia is associated with a higher degree of my...

Optic Nerve Diameter and Intraocular Pressure Changes in Patients Undergoing Vitrectomy Under General Anesthesia
https://clinicaltrials.gov/ct2/show/NCT05195801

Jan 24th, 2022 - The optic nerve is part of the central nervous system and is surrounded by the dura, arachnoid, and pia mater; The sheath surrounding the optic nerve is in continuity with the dura mater of the brain and the subarachnoidal space filled with cerebr...

see more →

News  126 results

Erectile Dysfunction Drugs Linked With Risk for Eye Problems
https://www.medscape.com/viewarticle/972431

Apr 20th, 2022 - Regular use of certain erectile dysfunction drugs — phosphodiesterase type 5 inhibitors (PDE5 inhibitors) — may be associated with an increased risk for several ocular adverse events, according to new research. In a cohort study of 213,033 men, th...

Sexual-Enhancement Drugs Raise Risk of Vision Impairment
https://www.medscape.com/viewarticle/972271

Apr 18th, 2022 - (Reuters Health) - Men who regularly used Viagra and other popular erectile dysfunction prescription drugs were more likely to suffer visual impairment, including retinal detachment and blindness, a large cohort study finds. The adjusted risks for...

Erectile Dysfunction Drugs Linked to Ocular Conditions
https://www.medscape.com/viewarticle/972064

Apr 13th, 2022 - People who use phosphodiesterase type 5 inhibitors (PDE5Is), a class of medications most often prescribed for erectile dysfunction, may run an increased risk of vision-threatening ocular conditions, researchers say. Patients in an insurance databa...

ED Meds Linked to Higher Risk of Ocular Adverse Events
https://www.medpagetoday.com/ophthalmology/generalophthalmology/98101

Apr 7th, 2022 - Regular users of common medications for erectile dysfunction (ED) are at a higher risk for ocular adverse events, according to a large cohort study. Among over 200,000 men using phosphodiesterase type 5 inhibitors (PDE5Is), the adjusted incidence ...

FDA Approves Eye Drops for Presbyopia
https://www.medscape.com/viewarticle/961999

Nov 1st, 2021 - Updated November 3, 2021 // Editor's Note: This story has been updated with additional comments from Dr Christopher Starr and Eyenovia COO Michael Rowe. The US Food and Drug Administration for the first time has approved an eye drop to treat presb...

see more →

Patient Education  9 results see all →